» Articles » PMID: 31744549

Implementation of Earlier Antibiotic Administration in Patients with Severe Sepsis and Septic Shock in Japan: a Descriptive Analysis of a Prospective Observational Study

Abstract

Background: Time to antibiotic administration is a key element in sepsis care; however, it is difficult to implement sepsis care bundles. Additionally, sepsis is different from other emergent conditions including acute coronary syndrome, stroke, or trauma. We aimed to describe the association between time to antibiotic administration and outcomes in patients with severe sepsis and septic shock in Japan.

Methods: This prospective observational study enrolled 1184 adult patients diagnosed with severe sepsis based on the Sepsis-2 criteria and admitted to 59 intensive care units (ICUs) in Japan between January 1, 2016, and March 31, 2017, as the sepsis cohort of the Focused Outcomes Research in Emergency Care in Acute Respiratory Distress Syndrome, Sepsis and Trauma (FORECAST) study. We compared the characteristics and in-hospital mortality of patients administered with antibiotics at varying durations after sepsis recognition, i.e., 0-60, 61-120, 121-180, 181-240, 241-360, and 361-1440 min, and estimated the impact of antibiotic timing on risk-adjusted in-hospital mortality using the generalized estimating equation model (GEE) with an exchangeable, within-group correlation matrix, with "hospital" as the grouping variable.

Results: Data from 1124 patients in 54 hospitals were used for analyses. Of these, 30.5% and 73.9% received antibiotics within 1 h and 3 h, respectively. Overall, the median time to antibiotic administration was 102 min [interquartile range (IQR), 55-189]. Compared with patients diagnosed in the emergency department [90 min (IQR, 48-164 min)], time to antibiotic administration was shortest in patients diagnosed in ICUs [60 min (39-180 min)] and longest in patients transferred from wards [120 min (62-226)]. Overall crude mortality was 23.4%, where patients in the 0-60 min group had the highest mortality (28.0%) and a risk-adjusted mortality rate [28.7% (95% CI 23.3-34.1%)], whereas those in the 61-120 min group had the lowest mortality (20.2%) and risk-adjusted mortality rates [21.6% (95% CI 16.5-26.6%)]. Differences in mortality were noted only between the 0-60 min and 61-120 min groups.

Conclusions: We could not find any association between earlier antibiotic administration and reduction in in-hospital mortality in patients with severe sepsis.

Citing Articles

The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2024.

Shime N, Nakada T, Yatabe T, Yamakawa K, Aoki Y, Inoue S Acute Med Surg. 2025; 12(1):e70037.

PMID: 39996161 PMC: 11848044. DOI: 10.1002/ams2.70037.


Early management of adult sepsis and septic shock: Korean clinical practice guidelines.

Park C, Ku N, Park D, Park J, Ha T, Kim D Acute Crit Care. 2024; 39(4):445-472.

PMID: 39622601 PMC: 11617831. DOI: 10.4266/acc.2024.00920.


Early identification and diagnosis, pathophysiology, and treatment of sepsis-related acute lung injury: a narrative review.

Zhang J, Yan W, Dong Y, Luo X, Miao H, Maimaijuma T J Thorac Dis. 2024; 16(8):5457-5476.

PMID: 39268131 PMC: 11388254. DOI: 10.21037/jtd-24-1191.


An observational study on the impact of overcrowding towards door-to-antibiotic time among sepsis patients presented to emergency department of a tertiary academic hospital.

Chau E, Bakar A, Zamhot A, Zaini I, Binti Adanan S, Sabardin D BMC Emerg Med. 2024; 24(1):58.

PMID: 38609924 PMC: 11015690. DOI: 10.1186/s12873-024-00973-4.


Epidemiology and patterns of empiric antimicrobial therapy practice in patients with community-onset sepsis using data from a Japanese nationwide medical claims database-the Japan Sepsis Alliance (JaSA) study group.

Abe T, Iriyama H, Imaeda T, Komori A, Oami T, Aizimu T IJID Reg. 2024; 10:162-167.

PMID: 38314396 PMC: 10835350. DOI: 10.1016/j.ijregi.2024.01.002.


References
1.
Barochia A, Cui X, Vitberg D, Suffredini A, OGrady N, Banks S . Bundled care for septic shock: an analysis of clinical trials. Crit Care Med. 2009; 38(2):668-78. PMC: 3383776. DOI: 10.1097/CCM.0b013e3181cb0ddf. View

2.
Abe T, Tokuda Y, Shiraishi A, Fujishima S, Mayumi T, Sugiyama T . In-hospital mortality associated with the misdiagnosis or unidentified site of infection at admission. Crit Care. 2019; 23(1):202. PMC: 6551884. DOI: 10.1186/s13054-019-2475-9. View

3.
Spiegel R, Farkas J, Rola P, Kenny J, Olusanya S, Marik P . The 2018 Surviving Sepsis Campaign's Treatment Bundle: When Guidelines Outpace the Evidence Supporting Their Use. Ann Emerg Med. 2018; 73(4):356-358. DOI: 10.1016/j.annemergmed.2018.06.046. View

4.
Deis A, Whiles B, Brown A, Satterwhite C, Simpson S . Three-Hour Bundle Compliance and Outcomes in Patients With Undiagnosed Severe Sepsis. Chest. 2017; 153(1):39-45. PMC: 6689078. DOI: 10.1016/j.chest.2017.09.031. View

5.
Alam N, Oskam E, Stassen P, van Exter P, van de Ven P, Haak H . Prehospital antibiotics in the ambulance for sepsis: a multicentre, open label, randomised trial. Lancet Respir Med. 2017; 6(1):40-50. DOI: 10.1016/S2213-2600(17)30469-1. View